Falsely Undetectable Vancomycin Levels in a Pediatric Patient With Chronic Granulomatous Disease

Pediatr Infect Dis J. 2022 Apr 1;41(4):302-303. doi: 10.1097/INF.0000000000003412.

Abstract

A child with chronic granulomatous disease on vancomycin treatment had V trough levels that became undetectable, as measured in our hospital's clinical laboratory by a commonly employed particle-enhanced turbidometric inhibition assay. An alternative laboratory method yielded appropriate results. Recognizing and resolving erroneously low V trough levels could prevent needless adjustments in dosing that could increase risk for acute kidney injury.

MeSH terms

  • Acute Kidney Injury*
  • Anti-Bacterial Agents / therapeutic use
  • Child
  • Female
  • Granulomatous Disease, Chronic* / complications
  • Granulomatous Disease, Chronic* / drug therapy
  • Humans
  • Male
  • Retrospective Studies
  • Vancomycin / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Vancomycin